Is the use of intranasal glucocorticosteroids (inGCSs) in children safe?

Journal Title: Otolaryngologia Polska - Year 2015, Vol 69, Issue 1

Abstract

It’s been 40 years since Niels Mygind publication in British Medical Journal on intranasal application of beclomethasonedipropionate aerosol in Allergic Rhinitis. Since then the new era in treatment of allergic and non-allergic upper airway diseases has begun.This publication presents current concepts on application of intranasal glucocorticosteroids in treatment of upper airway diseases and in particular of allergic rhinitis and rhinosinusitis.The non-questionable advantage of intranasal glucocorticosteroids is their strong anti-inflammatory local action with little impact on general health responsible for few and benign side effects. Main way of action of glucocorticosteroids is connected with binding to the intracellular glucocorticosteroid receptor and its impact on nuclear cytoplasmic transcriptional factors. Glucocorticosteroids suppress gene expression of factors responsible for generating and supporting inflammatory processes, pro-inflammatory cytokines and chemokines production, adhesive molecules expression. It appears that glucocorticosteroids has also other mechanisms of action, non-involving intracellular receptors, leading to inhibiting of early and late phase of allergic reaction.At the moment there are following glucocorticosteroids registered in Poland: beclomethasone, budesonide, fluticasone propionate, fluticasone fuorate, mometasonefuorate. Special attention earns fuorates as their lateral fuorate ester chain makes this molecules highly lipophilic, easily absorbed by nasal mucous membranes epithelium and cell membranes phospholipids. This minimizes their general action and maximizes local action. According to current state of knowledge topical glucocorticosteroids are used in the following upper airway diseases with different inflammatory mechanism: allergic rhinitis, non-allergic rhinitis, particularly NARES, acute rhinosinusitis, chronic rhinosinusitis with and without nasal polyps, adenoid hypertrophy and rhinitis in bronchial asthma.

Authors and Affiliations

Anna Nowicka, Bolesław Samoliński

Keywords

Related Articles

Guzy ślinianki przyusznej – obraz kliniczny, sposób postępowania i wyniki leczenia

Introduction. Tumors of the salivary glands are uncommon and represent 2–4% of head and neck neoplasms. Most tumors originate in the parotid gland, from which 10 to 15% are found to be malignant. Different methods of sur...

Franciszek Leopold Lafontaine (1756-1812) and his work on catarrh

The professional and scientifi c activities of Leopold Lafontaine (1756-1812), an eminent military surgeon, the chief army surgeon in the Grand Duchy of Warsaw are presented in full particular. He was a editor-in-chief a...

Morfologia głośni i charakterystyka percepcyjno-akustyczna głosu i mowy po laryngektomii fronto-lateralnej poszerzonej z następową epiglotoplastyką

For optimalisation glottis morphology and its phonatory function after frontolateral laryngectomy (FLL) the reconstruction of larynx is made; in Clinic of Otolaryngology the most common is using epiglottis wit or without...

Description of the bacterial flora and biofilms on the surface of the adenoids in children with chronic adenoiditis

SUMMARY Introduction: Development science doubtless serves to everyday life of peoples. We must however remember that of many inventions except oners own huge advantages possesses also activities undesirable. Aim: The ai...

Primary cholesteatoma of the middle ear and petrosal bone

Petrosal cholesteatomas are rare lesions, which may be primary or acquired in nature. We report a case of primary cholesteatoma in petrous bone occurring in 51-year old woman who presented with a unilateral facial nerve...

Download PDF file
  • EP ID EP52575
  • DOI -
  • Views 124
  • Downloads 0

How To Cite

Anna Nowicka, Bolesław Samoliński (2015). Is the use of intranasal glucocorticosteroids (inGCSs) in children safe?. Otolaryngologia Polska, 69(1), -. https://www.europub.co.uk/articles/-A-52575